Search

everythinglearnresearchcommunity

for

Search:↓

A woman with severe hair loss was successfully treated with the drug adalimumab.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

A Brazilian male with IFAP syndrome has a unique genetic variant causing his condition.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

Microparticles help caffeic acid stay longer in hair follicles for better treatment of folliculitis.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Fetal skin biopsy can help diagnose protein-related disorders before birth.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Isotretinoin and other medications showed promising results for treating a rare scalp condition linked to severe acne.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Patients with Frontal fibrosing alopecia in Morocco often have skin conditions and thyroid disorders.

The new filler effectively and safely improves tear trough deformity long-term.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Hair follicles are crucial for maintaining skin barrier function.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Titanium nanoparticles may trigger frontal fibrosing alopecia, so avoid products with them.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.